Acotec Scientific IPO: Living Right
Acotec has launched an HKEx IPO to raise net proceeds of $189 million at the mid-point of the IPO price range. Overall, we believe that Acotec’s...
420 Views
Acotec (先瑞达) IPO: Risk-Reward Does Not Warrant Participation
We look at the deal term and are of the view that the risk reward does not warrant a participation on Acotec at the high end.
316 Views
ECM Weekly (1st August 2021) - Cloud Village, Li Auto HK, Asymchem, Acotec, Devyani, Del Monte PH
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
275 Views
Acotec (先瑞达) Pre-IPO: Thoughts on Valuation
We provide our forecast and valuation for the company's two key products AcoArt Orchid & Dhalia, as well as AcoArt Tulip & Litos.
217 Views
Shanghai HeartCare (心玮医疗) Pre-IPO: Thoughts on Valuation
We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...
400 Views